Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin for postoperative lower extremity swelling after total knee arthroplasty
ChiCTR2100049077Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of diosmin in Postoperative lower extremity edema (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Swelling of lower limbs after surgery. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
diosmin
03
Conditions
Postoperative lower extremity edema
Beyond the preview
Go deeper on ChiCTR2100049077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049077.